Fig. 1: Restricted cubic splines describing the non-linear association between BMI and pCR among neoadjuvant targeted therapy treated HER2 positive breast cancer patients. | npj Breast Cancer

Fig. 1: Restricted cubic splines describing the non-linear association between BMI and pCR among neoadjuvant targeted therapy treated HER2 positive breast cancer patients.

From: Impact of body mass index in therapeutic response for HER2 positive breast cancer treated with neoadjuvant targeted therapy: a multi-center study and meta-analysis

Fig. 1: Restricted cubic splines describing the non-linear association between BMI and pCR among neoadjuvant targeted therapy treated HER2 positive breast cancer patients.The alternative text for this image may have been generated using AI.

Odds ratios are based on Logistic regression adjusted for age, clinical T stage, hormone receptor, HER2 staining intensity, Ki67, and neoadjuvant targeted therapy. The dotted lines represent the 95% confidence intervals for the spline model.

Back to article page